BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17923611)

  • 21. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
    Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    Visser PJ; Verhey FR; Hofman PA; Scheltens P; Jolles J
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):491-7. PubMed ID: 11909909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
    Korf ES; Wahlund LO; Visser PJ; Scheltens P
    Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.
    He J; Farias S; Martinez O; Reed B; Mungas D; Decarli C
    Arch Neurol; 2009 Nov; 66(11):1393-9. PubMed ID: 19901172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease.
    Wang L; Harms MP; Staggs JM; Xiong C; Morris JC; Csernansky JG; Galvin JE
    Arch Neurol; 2010 Jan; 67(1):99-106. PubMed ID: 20065136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of APOE in mild cognitive impairment.
    Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
    Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
    van de Pol LA; Verhey F; Frisoni GB; Tsolaki M; Papapostolou P; Nobili F; Wahlund LO; Minthon L; Frölich L; Hampel H; Soininen H; Knol DL; Barkhof F; Scheltens P; Visser PJ
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1069-74. PubMed ID: 19541689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
    Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
    J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.
    Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC;
    PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal volumetric MRI change and rate of cognitive decline.
    Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.
    Grundman M; Sencakova D; Jack CR; Petersen RC; Kim HT; Schultz A; Weiner MF; DeCarli C; DeKosky ST; van Dyck C; Thomas RG; Thal LJ;
    J Mol Neurosci; 2002; 19(1-2):23-7. PubMed ID: 12212787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
    Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
    Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment.
    Moretti DV; Miniussi C; Frisoni GB; Geroldi C; Zanetti O; Binetti G; Rossini PM
    Clin Neurophysiol; 2007 Dec; 118(12):2716-29. PubMed ID: 17977786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.